Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Panama
Panama: Diphtheria tetanus toxoid and pertussis third-dose (DTP3) was 80.0% in 2025. ▼ Falling
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Panama, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Panama stood at 80.0%.
That represents a change of up 11.1% on the previous year and up 9.6% over ten years.
Over the whole period, diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Panama peaked at 99.0% in 2001 and was at its lowest, 71.0%, in 2023.
That places Panama 153rd out of 194 countries with data for 2025, putting it in the bottom quarter.
The long-run direction has been consistently falling across the 26 years of available data.
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Panama, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 98.0% | — |
| 2001 | 99.0% | +1.0% |
| 2002 | 99.0% | +0.0% |
| 2003 | 98.0% | -1.0% |
| 2004 | 95.0% | -3.1% |
| 2005 | 92.0% | -3.2% |
| 2006 | 88.0% | -4.3% |
| 2007 | 85.0% | -3.4% |
| 2008 | 86.0% | +1.2% |
| 2009 | 85.0% | -1.2% |
| 2010 | 94.0% | +10.6% |
| 2011 | 87.0% | -7.4% |
| 2012 | 85.0% | -2.3% |
| 2013 | 80.0% | -5.9% |
| 2014 | 80.0% | +0.0% |
| 2015 | 73.0% | -8.8% |
| 2016 | 86.0% | +17.8% |
| 2017 | 81.0% | -5.8% |
| 2018 | 88.0% | +8.6% |
| 2019 | 88.0% | +0.0% |
| 2020 | 74.0% | -15.9% |
| 2021 | 87.0% | +17.6% |
| 2022 | 82.0% | -5.7% |
| 2023 | 71.0% | -13.4% |
| 2024 | 72.0% | +1.4% |
| 2025 | 80.0% | +11.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 92.5% | 85.0% | 99.0% | 10 |
| 2010s | 84.2% | 73.0% | 94.0% | 10 |
| 2020s | 77.7% | 71.0% | 87.0% | 6 |
Countries ranked near Panama
- 151 Ethiopia 81.0% compare
- 151 Cambodia 81.0% compare
- 153 Paraguay 80.0% compare
- 155 North Macedonia 79.0% compare
- 156 Equatorial Guinea 78.0% compare
More health data for Panama
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5994 % change on previous year (2090)
- Heat deaths vs projected death rates 1,074 (2090)
- Un projection of annual infant deaths 101 (2100)
- Population ages 15-64, male, annual growth rate 1.36 % change on previous year (2025)
- Population ages 15-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per capita 0.3306 units per person (2025)
- Population ages 15-64, total, annual growth rate 1.33 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, total, per capita 0.6582 units per person (2025)
Frequently asked questions
- What is diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Panama?
- Diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Panama was 80.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Panama?
- The highest recorded value was 99.0% in 2001.
- What is the lowest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Panama?
- The lowest recorded value was 71.0% in 2023.
- How does Panama rank for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Panama ranks 153rd out of 194 countries with data for 2025.
- Is diphtheria tetanus toxoid and pertussis third-dose (dtp3) rising or falling in Panama?
- Over the last ten years it is up 9.6%. The long-run trend across the full record is falling.
- Where does this Panama data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).